Loading...
Back to narrative

LIN: Earnings Momentum And Defensive Appeal Will Drive Share Performance Into 2026

Update shared on 26 Nov 2025

n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
8.7%
7D
-0.5%

Linde's analyst price target saw a slight decrease, dropping from $507 to $500, as analysts revised their outlook based on expectations for future earnings growth acceleration and the company's continued positioning as a defensive growth stock, even with ongoing sector challenges.

Analyst Commentary

Recent analyst reports reflect a balanced but nuanced outlook for Linde, with both positive and cautious perspectives shaping market sentiment. Adjusted targets and list changes point to an evolving landscape as the company navigates sector-specific headwinds and macroeconomic challenges.

Bullish Takeaways
  • Bullish analysts see the potential for earnings growth acceleration in 2026 as a key catalyst for Linde's stock performance.
  • Linde is positioned as a defensive growth stock, offering an attractive risk and reward profile even in uncertain times.
  • Recent adjustments bring the company’s price targets in line with its valuation. There are expectations that it is trading below its historical average multiple, which could represent an upside opportunity if market sentiment rebounds.
  • Despite ongoing sector challenges and weaker volumes, updated targets reflect continued confidence in Linde's long-term execution in the specialty chemicals space.
Bearish Takeaways
  • Bearish analysts have tempered their outlook by lowering price targets to reflect ongoing headwinds in end-market demand.
  • The stock's removal from select top ideas lists signals a degree of caution about near-term outperformance relative to peers.
  • Lower investor confidence in growth prospects, reflected in the company trading at a discount to its average multiple, may limit near-term upside potential.
  • Volume underperformance across key end markets continues to be a challenge and contributes to a cautious approach on valuation adjustments.

What's in the News

  • New U.S. import tariffs, as reported by Reuters, are disrupting global trade and threatening recovery for European chemical companies, including Linde (Reuters).
  • Linde completed another tranche of its stock buyback program by repurchasing over 2 million shares for nearly $1 billion between July and September 2025. This brings the total buyback under the current program to 13.89 million shares.
  • Linde has started up a new air separation unit to supply industrial gases across eastern Tennessee, northern Alabama, and Georgia. This enhances supply capabilities and supports regional growth.

Valuation Changes

  • Discount Rate: increased slightly from 8.03% to approximately 8.04%.
  • Revenue Growth: remained stable at about 5.53%.
  • Net Profit Margin: stayed consistent at roughly 23.91%.
  • Future P/E: rose modestly from 29.80x to 30.41x.
  • Fair Value: held steady at approximately $505.61.

Have other thoughts on Linde?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.